Intensity Therapeutics, Inc. secures $6.6 million for clinical trials, Trilogy Metals Inc. positions itself as a key player in the mining industry, a study explores EV battery reuse vs. recycling, and NRx Pharmaceuticals, Inc. petitions FDA for a ban on Benzethonium Chloride in ketamine products, focusing on developing safer therapeutics.

Neutra Life Sciences, a subsidiary of Neutra Corp, is expanding rapidly through joint venture partnerships with Podiatry Epic Foot & Ankle Centers, Radiation Oncology Aspire Hospital Cancer Centers, and Dermatology Radiant Dermatology & Aesthetics Clinic. This diversification into various specialties aims to meet the growing demand for high-quality clinical research solutions, accelerating the development of innovative treatments and reflecting a shift towards long-term growth in the life sciences sector.

Lahontan Gold Corp. and ESGold Corp. are leveraging past producers and innovative approaches to tap into the potential of gold mining, while researchers at the University of Kentucky have made strides in personalized cancer treatment through genetic biomarker identification for glioblastoma patients.

OncoX BioPharma, under the leadership of CEO Yen Wen Pin, is strengthening its collaboration with ABVC BioPharma by licensing four IND-stage drug assets to advance its immunotherapy-driven treatments in oncology. The partnership aims to create long-term value for patients and investors, with a focus on revenue-generating models and expansion into global markets to provide innovative therapies worldwide.

Oragenics Inc. partners with Southern Star Research for Phase IIa trial, Aston Bay Holdings Ltd. launches summer exploration program in Nunavut, and Soligenix achieves positive results in Behçet’s Disease study. Norvell Jefferson's BIO 2025 Pulse of the Industry Report highlights key forces driving innovation in the biotech sector.

Amerigo Scientific offers high-quality carotenoid standards with over 95% purity, ensuring accurate and reliable results for researchers in various fields. These standards meet strict quality control and stability requirements, providing confidence in data accuracy and compliance with global testing standards. Visit their website for more information.

NanoViricides, Inc. introduces NV-387 as a promising treatment for the rising measles cases in multiple countries, with potential for expedited approval. ESGold Corp. is gaining attention for its revenue-focused strategy of rehabilitating a legacy mine site in Quebec, aiming for profitable metal and mineral recovery.

Royalty Management Holding Corporation has expanded its sampling program at T.R. Mining, uncovering economically viable titanium, vanadium, and rare earth elements. With plans to extract and sell these valuable minerals, the company aims to hire local personnel in Jamaica, providing employment opportunities and maximizing the resource's value for shareholders and communities.

NanoCell Therapeutics, Inc. introduces a game-changing study on in vivo CAR-T cell generation, potentially transforming accessibility to $300,000 therapies. Ucore Rare Metals Inc. garners attention for its upcoming rare earths plant in Louisiana, poised to impact defense, EV, and electronics industries positively. Meanwhile, volatility in markets affects the oil and gas sector, with Nicola Mining Inc. making significant strides in gold-silver exploration in British Columbia.

Scinai Immunotherapeutics is exploring a novel disease-modifying antibody for pemphigus, while GeoVax Labs is fast-tracking a vaccine for Mpox crisis. Creative Biolabs is pioneering single-domain antibody solutions with high potency against various pathogens, offering valuable insights for oncology, neurology, and infectious disease research. Additionally, they will host a webinar on tumoroid-on-a-chip platform for preclinical testing in oncology research.